ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Neuroprotective effect of astragalin via activating PI3K/Akt-mTOR-mediated autophagy on APP/PS1 mice

Yang, Cui-Zhu; Wang, Shu-Han; Zhang, Run-Heng; Lin, Jia-Hong; Tian, Ying-Hong; Yang, Ya-Qi; Liu, Jing; Ma, Yu-Xin*广东药学院; 南方医科大学
Cell Death Discovery2023-1-21DOI: 10.1038/s41420-023-01324-1
6被引2阅读
引用收藏
分享

摘要

As a small molecule flavonoid, astragalin (AST) has anti-inflammatory, anti-cancer, and anti-oxidation effects. However, the impact and molecular mechanism of AST in Alzheimer's disease (AD) are still not clear. This study aims to investigate the neuroprotective effect and mechanism of AST on APP/PS1 mice and A beta 25-35-injured HT22 cells. In this study, we found that AST ameliorated cognitive dysfunction, reduced hippocampal neuronal damage and loss, and A beta pathology in APP/PS1 mice. Subsequently, AST activated autophagy and up-regulated the levels of autophagic flux-related protein in APP/PS1 mice and A beta 25-35-induced injury in HT22 cells. Interestingly, AST down-regulated the phosphorylation level of PI3K/Akt-mTOR pathway-related proteins, which was reversed by autophagy inhibitors 3-Methyladenine (3-MA) or Bafilomycin A1 (Baf A1). At the same time, consistent with the impacts of Akt inhibitor MK2206 and mTOR inhibitor rapamycin, inhibited levels of autophagy in A beta 25-35-injured HT22 cells were activated by the administration of AST. Taken together, these results suggested that AST played key neuroprotective roles on AD via stimulating PI3K/Akt-mTOR pathway-mediated autophagy and autophagic flux. This study revealed a new mechanism of autophagy regulation behind the neuroprotection impact of AST for AD treatment.

学科与关键词

关键词
CELL-CYCLE ARRESTALZHEIMERS-DISEASEPATHWAYPI3K/AKT/MTORMODULATIONAPOPTOSISMODEL
相关
加载中…
  • Clemastine attenuates AD-like pathology in an AD model mouse via enhancing mTOR-mediated autophagy
    Li, Zhen-Yu; Chen, Li-Hua; Zhao, Xiu-Yun; Chen, Hong; Sun, Yan-Yun; Lu, Mei-Hong; Wang, Zhao-Tao; Chen, Mei; Lu, Li; Huang, Wenhui; Chen, Rui; Xu, De-En*; Xu, Ru-Xiang*; Ma, Quan-Hong*Experimental Neurology, 2021, 342: 113742.被引 17
  • MRTF-A-mediated protection against amyloid-β-induced neuronal injury correlates with restoring autophagy via miR-1273g-3p/mTOR axis in Alzheimer models
    Zhang, Wei; Yang, Yuewang; Xiang, Zifei; Cheng, Jinping; Yu, Zhijun; Wang, Wen; Hu, Ling; Ma, Fuyun; Deng, Youping; Jin, Zhigang*; Hu, Xiamin*Aging-US, 2022, 14(10): 4305-4325.被引 6
  • β-asarone Protects p-tau from Okadaic Acid in PC12 Cells by Activating PP2A and Involving Akt/mTOR/Beclin-1 Pathway
    Huang, Liping; Zhong, Xiaoqin; Xu, Yuanhang; Deng, Minzhen*; Zhou, Zhongliu*Pharmacognosy Magazine, 2023, 19(3): 727-735.
查看全部 →

发表信息

论文状态
公开发表
期刊
Cell Death Discovery
发表日期
2023-01-21
卷期
第 9 卷, 第 1 期
页码
15
DOI
10.1038/s41420-023-01324-1
成果收录
SCIE
资助标注
Medical Scientific Research Foundation of Guangdong Province [B2022076]; Project of Administration of Traditional Chinese Medicine of Guangdong Province [20231201]; Natural Science Foundation of Guangdong Province [2018A0303130073]; Pearl River S&T Nova Program Foundation of Guangzhou City of China [201710010002]

作者

  • Y

    Yang, Cui-Zhu (第一作者)

    guangdong pharmaceut univ

  • W

    Wang, Shu-Han

    guangdong pharmaceut univ

查看全部 8 位作者收起作者
  • Z

    Zhang, Run-Heng

    guangdong pharmaceut univ

  • L

    Lin, Jia-Hong

    guangdong pharmaceut univ

  • T

    Tian, Ying-Hong

    southern med univ

  • Y

    Yang, Ya-Qi

    guangdong pharmaceut univ

  • L

    Liu, Jing

    guangdong pharmaceut univ

  • M

    Ma, Yu-Xin (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417